PreveCeutical Medical Inc. (FRA:18H0)

Germany flag Germany · Delayed Price · Currency is EUR
0.0049
-0.0031 (-38.75%)
At close: Dec 19, 2025
-69.38%
Market Cap7.27M
Revenue (ttm)n/a
Net Income (ttm)-1.91M
Shares Outn/a
EPS (ttm)-0.00
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume12,500
Open0.0049
Previous Close0.0080
Day's Range0.0049 - 0.0049
52-Week Range0.0049 - 0.0300
Betan/a
RSI40.26
Earnings DateDec 5, 2025

About PreveCeutical Medical

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its research and development programs include dual gene therapy for curative and prevention therapies for diabetes and obesity; the Sol-gel Program; Nature Identical peptides for treatment of various ailments; nonaddictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating ... [Read more]

Industry Pharmaceutical Preparations
CEO Stephen Van Deventer
Country Canada
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 18H0
Full Company Profile

Financial Performance

Financial numbers in CAD Financial Statements

News

There is no news available yet.